Study Links Fructose to Ovarian Cancer Spread After Chemotherapy

A new preclinical study suggests chemotherapy-surviving ovarian cancer cells release fructose that may promote tumor spread in laboratory and mouse models. Learn what the findings mean, and what they don’t.

High-grade serous ovarian cancer (HGSOC) is the most common and aggressive form of ovarian cancer (1^✔ ✔Trusted Source
The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming

Go to source

).
Although many patients initially respond well to platinum-based chemotherapy, the disease frequently returns. Most deaths occur after the cancer spreads throughout the abdominal cavity, making metastasis the greatest challenge in treatment.

Why Did Researchers Study Fructose?

Scientists have known that some ovarian cancer cells survive chemotherapy by entering a state called cellular senescence. These cells stop dividing but remain biologically active, releasing a mixture of signaling molecules known as the senescence-associated secretory phenotype (SASP).

The researchers wanted to identify which of these secreted molecules encourage nearby cancer cells to detach from the primary tumor and spread.

What Did the Researchers Discover?

The study identified fructose as one of the metabolic signals released by chemotherapy-treated ovarian cancer cells.

Instead of directly stimulating cancer cell growth, fructose appeared to make neighboring cancer cells less sticky, allowing them to separate more easily from the tumor and spread within the abdomen.

In mouse models, researchers found:

• Chemotherapy-surviving cancer cells released fructose
• Fructose promoted cancer cell detachment
• A high-fructose diet also increased tumor dissemination

These findings suggest fructose may influence how ovarian cancer spreads under experimental conditions.

How Does Fructose Help Cancer Cells Spread?

The team discovered that fructose triggered a chain of metabolic changes inside neighboring cancer cells.

Normally, cholesterol helps cells remain attached to one another, acting like a biological adhesive.

Fructose reduced cholesterol production inside cancer cells, weakening these connections and making it easier for cells to detach and migrate to new sites.

The researchers linked this process to changes in cholesterol-regulating pathways involving NAD+, SIRT proteins, SREBP1, and mitochondrial metabolism.

Can Sugary Drinks Increase Ovarian Cancer Spread?

One of the study’s notable findings was that high levels of fructose similar to those found in sugar-sweetened beverages increased cancer dissemination in mice.

However, this does not mean drinking sugary beverages causes ovarian cancer to spread in people.

Human studies are still needed to determine whether reducing dietary fructose influences cancer progression or treatment outcomes.

Could Cholesterol-Lowering Drugs Also Play a Role?

The researchers also observed that lowering cholesterol production using statins produced similar effects on cancer cell detachment in laboratory experiments.

Because many women with ovarian cancer also take statins for cardiovascular disease, the authors say future research should investigate whether these medications influence chemotherapy responses.

Importantly, the researchers emphasize that patients should not stop taking prescribed statins based on this study. Clinical studies are needed before any treatment recommendations can be made.

What Does This Mean for Patients?

Although the findings are promising, they should not change current treatment or dietary recommendations.

The study was conducted in laboratory models and mice, not in people.

Researchers say the results provide a better understanding of how chemotherapy-surviving cancer cells may promote metastasis and could eventually help identify new treatment strategies that block these signaling pathways.

Understanding the Findings at a Glance

What Are the Next Steps?

The research team plans to investigate:

• Whether similar mechanisms occur in people with ovarian cancer
• Whether dietary fructose restriction can improve treatment outcomes
• Whether this pathway also contributes to the spread of pancreatic, liver, and colorectal cancers
• Whether therapies targeting fructose signaling or cholesterol metabolism can reduce metastasis

Reference:

1. The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming – (https://www.nature.com/articles/s43587-026-01172-5)

Source-Medindia